Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.

Leslie Joan Berg

TitleProfessor
InstitutionUniversity of Colorado Denver - Anschutz Medical Campus
DepartmentSOM-IMM MICRO GENERAL OPER
Email

    Collapse Biography 
    Collapse education and training
    Harvard University, Cambridge, MABA1980Biology
    University of California, BerkeleyPhD1986Molecular Biology
    Stanford University Medical School, Stanford, Ca1990Postdoc training
    Collapse awards and honors
    1980Phi Beta Kappa, Harvard University
    1980 - 1980NSF Fellowship
    1986 - 1987Cancer Biology Postdoc Fellowship, Stanford University
    1987 - 1990Postdoctoral Fellowship, Leukemia Society
    1990 - 1994Investigator Award, Cancer Research Institute
    1993 - 1995Young Investigator Award, Harcourt General Charitable Foundation
    2001Pharmigen Investigator Award, AAI
    2002Outstanding Educator Award, Univ. Massachusetts Medical School
    2002Award for Excellence in Medical Research, Medical Foundation's Chestnut Hill Award
    2003Educational Achievement Star Award, Univ. Massachusetts Medical School
    2004Women in Science and Health Achievement Award, Univ. Massachusetts Medical School
    2006Faculty Achievement Award for outstanding mentoring, Univ. Massachusetts Medical School
    2006Distinguished Service Award, AAI
    2010Dean's Award, Lamar Soutter Award for Excellence
    2011 - 2012President, AAI
    2017Educational Achievement Star Award, Univ. Massachusetts Medical School

    Collapse Research 
    Collapse research activities and funding
    R01AI143976     (HUSEBY, ERIC S)Dec 4, 2019 - Nov 30, 2024
    NIH
    TCR signaling control of thymic Treg selection and immune homeostasis
    Role: Co-Principal Investigator
    R01AI132419     (BERG, LESLIE JOAN)Jan 24, 2018 - Dec 31, 2023
    NIH
    Dissecting the pathways controlling tunable responses to TCR signaling
    Role: Principal Investigator
    R01AI106833     (BERG, LESLIE J)Apr 15, 2014 - Mar 31, 2018
    NIH
    Regulation of anti-viral T cell responses by IRF4
    Role: Principal Investigator
    R01AI101048     (BERG, LESLIE J)May 25, 2013 - Apr 30, 2017
    NIH
    Plasticity of T helper cell differentiation
    Role: Principal Investigator
    R13AI094757     (BERG, LESLIE J.)May 1, 2011 - Apr 30, 2012
    NIH
    FASEB SRC on Signal Transduction in the Immune System
    Role: Principal Investigator
    R01AI083505     (KANG, JOONSOO)Dec 1, 2010 - Nov 30, 2015
    NIH
    ITK: an emerging target for treatment of T cell-mediated autoimmune disease
    Role: Co-Principal Investigator
    R01AI084987     (BERG, LESLIE J)Sep 30, 2010 - Aug 31, 2015
    NIH
    Regulation of conventional versus innate CD8+ T cell development
    Role: Principal Investigator
    R21NS071548     (BERG, LESLIE J.)Jul 1, 2010 - Jun 30, 2012
    NIH
    Screening for inhibitors of the T cell Tec kinase, ltk
    Role: Co-Principal Investigator
    R01AI066118     (BERG, LESLIE J)Mar 1, 2006 - Feb 28, 2010
    NIH
    Tec Kinases ltk and RlK in Mast Cell Signaling
    Role: Principal Investigator
    R01CI000101     (BERG, LESLIE J.)Sep 15, 2003 - Sep 14, 2008
    NIH
    Response to viral infection in immunodeficient mice
    Role: Principal Investigator
    R13AI051363     (BERG, LESLIE J.)Jun 1, 2002 - May 31, 2003
    NIH
    FASEB Summer Research Conference: Lymphocytes/Antibodies
    Role: Principal Investigator
    R01AI046564     (BERG, LESLIE J.)Mar 1, 2000 - Jan 31, 2011
    NIH
    Immunobiology of Jak3 Deficient Mice
    Role: Principal Investigator
    R01AI043957     (ANDREOTTI, AMY H)Jan 15, 1999 - Jul 31, 2029
    NIH
    Structural Studies of a T cell Specific Tyrosine Kinase
    Role: Co-Principal Investigator
    R01AI037584     (BERG, LESLIE J)Sep 30, 1995 - Jan 31, 2010
    NIH
    Tec family tyrosine kinases in T cell signaling
    Role: Principal Investigator
    R01AI032494     (BERG, LESLIE J.)Sep 30, 1994 - Jun 30, 2004
    NIH
    THYMIC SELECTION AND T CELL LINEAGE COMMITMENT
    Role: Principal Investigator
    R55AI029953     (BERG, LESLIE J.)Sep 30, 1991 - Aug 31, 1993
    NIH
    FUNCTION OF MHC CLASS II MUTANTS
    Role: Principal Investigator

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Perrenoud L, Conley J, Berg LJ. Analysis of T-cell Receptor-Induced Calcium Influx in Primary Murine T-cells by Full Spectrum Flow Cytometry. J Vis Exp. 2022 12 16; (190). PMID: 36591968.
      View in: PubMed
    2. Forconi CS, Mulama DH, Saikumar Lakshmi P, Foley J, Otieno JA, Kurtis JD, Berg LJ, Ong'echa JM, M?nz C, Moormann AM. Interplay between IL-10, IFN-?, IL-17A and PD-1 Expressing EBNA1-Specific CD4+ and CD8+ T Cell Responses in the Etiologic Pathway to Endemic Burkitt Lymphoma. Cancers (Basel). 2021 Oct 27; 13(21). PMID: 34771539.
      View in: PubMed
    3. Gallagher MP, Conley JM, Vangala P, Garber M, Reboldi A, Berg LJ. Hierarchy of signaling thresholds downstream of the T cell receptor and the Tec kinase ITK. Proc Natl Acad Sci U S A. 2021 08 31; 118(35). PMID: 34452995.
      View in: PubMed
    4. Riggs JB, Medina EM, Perrenoud LJ, Bonilla DL, Clambey ET, van Dyk LF, Berg LJ. Optimized Detection of Acute MHV68 Infection With a Reporter System Identifies Large Peritoneal Macrophages as a Dominant Target of Primary Infection. Front Microbiol. 2021; 12:656979. PMID: 33767688.
      View in: PubMed
    5. Conley JM, Gallagher MP, Rao A, Berg LJ. Activation of the Tec Kinase ITK Controls Graded IRF4 Expression in Response to Variations in TCR Signal Strength. J Immunol. 2020 07 15; 205(2):335-345. PMID: 32493815.
      View in: PubMed
    6. Cho HS, Ha S, Shin HM, Reboldi A, Hall JA, Huh JR, Usherwood EJ, Berg LJ. CD8+ T Cells Require ITK-Mediated TCR Signaling for Migration to the Intestine. Immunohorizons. 2020 02 07; 4(2):57-71. PMID: 32034085.
      View in: PubMed
    7. Conley JM, Berg LJ. TCR signaling: it's all about the numbers. Nat Immunol. 2019 11; 20(11):1415-1416. PMID: 31591572.
      View in: PubMed
    8. Cho HS, Reboldi A, Hall JA, Berg LJ. The Tec kinase ITK is essential for ILC2 survival and epithelial integrity in the intestine. Nat Commun. 2019 02 15; 10(1):784. PMID: 30770814.
      View in: PubMed
    9. Gallagher MP, Conley JM, Berg LJ. Peptide Antigen Concentration Modulates Digital NFAT1 Activation in Primary Mouse Naive CD8+ T Cells as Measured by Flow Cytometry of Isolated Cell Nuclei. Immunohorizons. 2018 Aug; 2(7):208-215. PMID: 30221251.
      View in: PubMed
    10. Olesin E, Nayar R, Saikumar-Lakshmi P, Berg LJ. The Transcription Factor Runx2 Is Required for Long-Term Persistence of Antiviral CD8+ Memory T Cells. Immunohorizons. 2018 Aug; 2(7):251-261. PMID: 30264035.
      View in: PubMed
    11. Andreotti AH, Joseph RE, Conley JM, Iwasa J, Berg LJ. Multidomain Control Over TEC Kinase Activation State Tunes the T Cell Response. Annu Rev Immunol. 2018 04 26; 36:549-578. PMID: 29677469.
      View in: PubMed
    12. Berg L, Krangel M. On the Horizon. Immunohorizons. 2018 01 17; 2(1):26. PMID: 31022689.
      View in: PubMed
    13. Shin HM, Kapoor VN, Kim G, Li P, Kim HR, Suresh M, Kaech SM, Wherry EJ, Selin LK, Leonard WJ, Welsh RM, Berg LJ. Transient expression of ZBTB32 in anti-viral CD8+ T cells limits the magnitude of the effector response and the generation of memory. PLoS Pathog. 2017 Aug; 13(8):e1006544. PMID: 28827827.
      View in: PubMed
    14. Falanga YT, Frascoli M, Kaymaz Y, Forconi C, Ong'echa JM, Bailey JA, Berg LJ, Moormann AM. High pathogen burden in childhood promotes the development of unconventional innate-like CD8+ T cells. JCI Insight. 2017 Aug 03; 2(15). PMID: 28768916.
      View in: PubMed
    15. Gallagher MP, Berg LJ. Gene-enhancer variants reveal diverse TCR-mediated differentiation. Nat Immunol. 2017 04 18; 18(5):483-484. PMID: 28418392.
      View in: PubMed
    16. Marshall NB, Vong AM, Devarajan P, Brauner MD, Kuang Y, Nayar R, Schutten EA, Castonguay CH, Berg LJ, Nutt SL, Swain SL. NKG2C/E Marks the Unique Cytotoxic CD4 T Cell Subset, ThCTL, Generated by Influenza Infection. J Immunol. 2017 02 01; 198(3):1142-1155. PMID: 28031335.
      View in: PubMed
    17. Urban SL, Berg LJ, Welsh RM. Type 1 interferon licenses na?ve CD8 T cells to mediate anti-viral cytotoxicity. Virology. 2016 06; 493:52-9. PMID: 26999026.
      View in: PubMed
    18. Conley JM, Gallagher MP, Berg LJ. T Cells and Gene Regulation: The Switching On and Turning Up of Genes after T Cell Receptor Stimulation in CD8 T Cells. Front Immunol. 2016; 7:76. PMID: 26973653.
      View in: PubMed
    19. Nayar R, Schutten E, Jangalwe S, Durost PA, Kenney LL, Conley JM, Daniels K, Brehm MA, Welsh RM, Berg LJ. IRF4 Regulates the Ratio of T-Bet to Eomesodermin in CD8+ T Cells Responding to Persistent LCMV Infection. PLoS One. 2015; 10(12):e0144826. PMID: 26714260.
      View in: PubMed
    20. Cho HS, Shin HM, Haberstock-Debic H, Xing Y, Owens TD, Funk JO, Hill RJ, Bradshaw JM, Berg LJ. A Small Molecule Inhibitor of ITK and RLK Impairs Th1 Differentiation and Prevents Colitis Disease Progression. J Immunol. 2015 Nov 15; 195(10):4822-31. PMID: 26466958.
      View in: PubMed
    21. Wu T, Shin HM, Moseman EA, Ji Y, Huang B, Harly C, Sen JM, Berg LJ, Gattinoni L, McGavern DB, Schwartzberg PL. TCF1 Is Required for the T Follicular Helper Cell Response to Viral Infection. Cell Rep. 2015 Sep 29; 12(12):2099-110. PMID: 26365183.
      View in: PubMed
    22. Sharma S, Campbell AM, Chan J, Schattgen SA, Orlowski GM, Nayar R, Huyler AH, N?ndel K, Mohan C, Berg LJ, Shlomchik MJ, Marshak-Rothstein A, Fitzgerald KA. Suppression of systemic autoimmunity by the innate immune adaptor STING. Proc Natl Acad Sci U S A. 2015 Feb 17; 112(7):E710-7. PMID: 25646421.
      View in: PubMed
    23. Pereira RM, Martinez GJ, Engel I, Cruz-Guilloty F, Barboza BA, Tsagaratou A, Lio CW, Berg LJ, Lee Y, Kronenberg M, Bandukwala HS, Rao A. Jarid2 is induced by TCR signalling and controls iNKT cell maturation. Nat Commun. 2014 Aug 08; 5:4540. PMID: 25105474.
      View in: PubMed
    24. Prince AL, Kraus Z, Carty SA, Ng C, Yin CC, Jordan MS, Schwartzberg PL, Berg LJ. Development of innate CD4+ and CD8+ T cells in Itk-deficient mice is regulated by distinct pathways. J Immunol. 2014 Jul 15; 193(2):688-99. PMID: 24943215.
      View in: PubMed
    25. Kapoor VN, Shin HM, Cho OH, Berg LJ, Kang J, Welsh RM. Regulation of tissue-dependent differences in CD8+ T cell apoptosis during viral infection. J Virol. 2014 Sep 01; 88(17):9490-503. PMID: 24942579.
      View in: PubMed
    26. Prince AL, Watkin LB, Yin CC, Selin LK, Kang J, Schwartzberg PL, Berg LJ. Innate PLZF+CD4+ a? T cells develop and expand in the absence of Itk. J Immunol. 2014 Jul 15; 193(2):673-87. PMID: 24928994.
      View in: PubMed
    27. Nayar R, Schutten E, Bautista B, Daniels K, Prince AL, Enos M, Brehm MA, Swain SL, Welsh RM, Berg LJ. Graded levels of IRF4 regulate CD8+ T cell differentiation and expansion, but not attrition, in response to acute virus infection. J Immunol. 2014 Jun 15; 192(12):5881-93. PMID: 24835398.
      View in: PubMed
    28. Jain N, Miu B, Jiang JK, McKinstry KK, Prince A, Swain SL, Greiner DL, Thomas CJ, Sanderson MJ, Berg LJ, Kang J. CD28 and ITK signals regulate autoreactive T cell trafficking. Nat Med. 2013 Dec; 19(12):1632-7. PMID: 24270545.
      View in: PubMed
    29. Shin HM, Kapoor V, Guan T, Kaech SM, Welsh RM, Berg LJ. Epigenetic modifications induced by Blimp-1 Regulate CD8? T cell memory progression during acute virus infection. Immunity. 2013 Oct 17; 39(4):661-75. PMID: 24120360.
      View in: PubMed
    30. Joseph RE, Kleino I, Wales TE, Xie Q, Fulton DB, Engen JR, Berg LJ, Andreotti AH. Activation loop dynamics determine the different catalytic efficiencies of B cell- and T cell-specific tec kinases. Sci Signal. 2013 Aug 27; 6(290):ra76. PMID: 23982207.
      View in: PubMed
    31. Malhotra N, Narayan K, Cho OH, Sylvia KE, Yin C, Melichar H, Rashighi M, Lefebvre V, Harris JE, Berg LJ, Kang J. A network of high-mobility group box transcription factors programs innate interleukin-17 production. Immunity. 2013 Apr 18; 38(4):681-93. PMID: 23562159.
      View in: PubMed
    32. Yin CC, Cho OH, Sylvia KE, Narayan K, Prince AL, Evans JW, Kang J, Berg LJ. The Tec kinase ITK regulates thymic expansion, emigration, and maturation of ?d NKT cells. J Immunol. 2013 Mar 15; 190(6):2659-69. PMID: 23378428.
      View in: PubMed
    33. Berg LJ. Signaling pathways that regulate T cell development and differentiation. J Immunol. 2012 Dec 15; 189(12):5487-8. PMID: 23225893.
      View in: PubMed
    34. Nayar R, Enos M, Prince A, Shin H, Hemmers S, Jiang JK, Klein U, Thomas CJ, Berg LJ. TCR signaling via Tec kinase ITK and interferon regulatory factor 4 (IRF4) regulates CD8+ T-cell differentiation. Proc Natl Acad Sci U S A. 2012 Oct 09; 109(41):E2794-802. PMID: 23011795.
      View in: PubMed
    35. Narayan K, Sylvia KE, Malhotra N, Yin CC, Martens G, Vallerskog T, Kornfeld H, Xiong N, Cohen NR, Brenner MB, Berg LJ, Kang J. Intrathymic programming of effector fates in three molecularly distinct ?d T cell subtypes. Nat Immunol. 2012 Apr 01; 13(5):511-8. PMID: 22473038.
      View in: PubMed
    36. Chang JT, Ciocca ML, Kinjyo I, Palanivel VR, McClurkin CE, Dejong CS, Mooney EC, Kim JS, Steinel NC, Oliaro J, Yin CC, Florea BI, Overkleeft HS, Berg LJ, Russell SM, Koretzky GA, Jordan MS, Reiner SL. Asymmetric proteasome segregation as a mechanism for unequal partitioning of the transcription factor T-bet during T lymphocyte division. Immunity. 2011 Apr 22; 34(4):492-504. PMID: 21497118.
      View in: PubMed
    37. Gertow J, Berglund S, Okas M, Uzunel M, Berg L, K?rre K, Mattsson J, Uhlin M. Characterization of long-term mixed donor-donor chimerism after double cord blood transplantation. Clin Exp Immunol. 2010 Oct; 162(1):146-55. PMID: 20731674.
      View in: PubMed
    38. Marshall HD, Prince AL, Berg LJ, Welsh RM. IFN-alpha beta and self-MHC divert CD8 T cells into a distinct differentiation pathway characterized by rapid acquisition of effector functions. J Immunol. 2010 Aug 01; 185(3):1419-28. PMID: 20592282.
      View in: PubMed
    39. Andreotti AH, Schwartzberg PL, Joseph RE, Berg LJ. T-cell signaling regulated by the Tec family kinase, Itk. Cold Spring Harb Perspect Biol. 2010 Jul; 2(7):a002287. PMID: 20519342.
      View in: PubMed
    40. Min L, Wu W, Joseph RE, Fulton DB, Berg L, Andreotti AH. Disrupting the intermolecular self-association of Itk enhances T cell signaling. J Immunol. 2010 Apr 15; 184(8):4228-35. PMID: 20237289.
      View in: PubMed
    41. Berg LJ. Strength of T cell receptor signaling strikes again. Immunity. 2009 Oct 16; 31(4):529-31. PMID: 19833081.
      View in: PubMed
    42. Shi M, Lin TH, Appell KC, Berg LJ. Cell cycle progression following naive T cell activation is independent of Jak3/common gamma-chain cytokine signals. J Immunol. 2009 Oct 01; 183(7):4493-501. PMID: 19734221.
      View in: PubMed
    43. Sacrist?n C, Schattgen SA, Berg LJ, Bunnell SC, Roy AL, Rosenstein Y. Characterization of a novel interaction between transcription factor TFII-I and the inducible tyrosine kinase in T cells. Eur J Immunol. 2009 Sep; 39(9):2584-95. PMID: 19701889.
      View in: PubMed
    44. Felices M, Yin CC, Kosaka Y, Kang J, Berg LJ. Tec kinase Itk in gammadeltaT cells is pivotal for controlling IgE production in vivo. Proc Natl Acad Sci U S A. 2009 May 19; 106(20):8308-13. PMID: 19416854.
      View in: PubMed
    45. Prince AL, Yin CC, Enos ME, Felices M, Berg LJ. The Tec kinases Itk and Rlk regulate conventional versus innate T-cell development. Immunol Rev. 2009 Mar; 228(1):115-31. PMID: 19290924.
      View in: PubMed
    46. Schepis D, D'Amato M, Studahl M, Bergstr?m T, K?rre K, Berg L. Herpes simplex virus infection downmodulates NKG2D ligand expression. Scand J Immunol. 2009 May; 69(5):429-36. PMID: 19508374.
      View in: PubMed
    47. Wu W, Berg LJ. c-Abl, an additional tyrosine kinase required for T cell development and function. Cell Cycle. 2008 Dec 15; 7(24):3791. PMID: 19151583.
      View in: PubMed
    48. Berg LJ. The "bubble boy" paradox: an answer that led to a question. J Immunol. 2008 Nov 01; 181(9):5815-6. PMID: 18941168.
      View in: PubMed
    49. Shi M, Lin TH, Appell KC, Berg LJ. Janus-kinase-3-dependent signals induce chromatin remodeling at the Ifng locus during T helper 1 cell differentiation. Immunity. 2008 Jun; 28(6):763-73. PMID: 18549798.
      View in: PubMed
    50. Felices M, Berg LJ. The Tec kinases Itk and Rlk regulate NKT cell maturation, cytokine production, and survival. J Immunol. 2008 Mar 01; 180(5):3007-18. PMID: 18292523.
      View in: PubMed
    51. Lucas JA, Felices M, Evans JW, Berg LJ. Subtle defects in pre-TCR signaling in the absence of the Tec kinase Itk. J Immunol. 2007 Dec 01; 179(11):7561-7. PMID: 18025201.
      View in: PubMed
    52. Berg LJ. Signalling through TEC kinases regulates conventional versus innate CD8(+) T-cell development. Nat Rev Immunol. 2007 Jun; 7(6):479-85. PMID: 17479128.
      View in: PubMed
    53. Felices M, Falk M, Kosaka Y, Berg LJ. Tec kinases in T cell and mast cell signaling. Adv Immunol. 2007; 93:145-84. PMID: 17383541.
      View in: PubMed
    54. Kosaka Y, Felices M, Berg LJ. Itk and Th2 responses: action but no reaction. Trends Immunol. 2006 Oct; 27(10):453-60. PMID: 16931156.
      View in: PubMed
    55. Atherly LO, Lucas JA, Felices M, Yin CC, Reiner SL, Berg LJ. The Tec family tyrosine kinases Itk and Rlk regulate the development of conventional CD8+ T cells. Immunity. 2006 Jul; 25(1):79-91. PMID: 16860759.
      View in: PubMed
    56. Mayack SR, Berg LJ. Cutting edge: an alternative pathway of CD4+ T cell differentiation is induced following activation in the absence of gamma-chain-dependent cytokine signals. J Immunol. 2006 Feb 15; 176(4):2059-63. PMID: 16455959.
      View in: PubMed
    57. Atherly LO, Brehm MA, Welsh RM, Berg LJ. Tec kinases Itk and Rlk are required for CD8+ T cell responses to virus infection independent of their role in CD4+ T cell help. J Immunol. 2006 Feb 01; 176(3):1571-81. PMID: 16424186.
      View in: PubMed
    58. Li CR, Berg LJ. Itk is not essential for CD28 signaling in naive T cells. J Immunol. 2005 Apr 15; 174(8):4475-9. PMID: 15814667.
      View in: PubMed
    59. Berg LJ, Finkelstein LD, Lucas JA, Schwartzberg PL. Tec family kinases in T lymphocyte development and function. Annu Rev Immunol. 2005; 23:549-600. PMID: 15771581.
      View in: PubMed
    60. Miller AT, Wilcox HM, Lai Z, Berg LJ. Signaling through Itk promotes T helper 2 differentiation via negative regulation of T-bet. Immunity. 2004 Jul; 21(1):67-80. PMID: 15345221.
      View in: PubMed
    61. Berg LJ, Nussenzweig M. Signals that regulate lymphocyte development and differentiation. Curr Opin Immunol. 2004 Apr; 16(2):163-6. PMID: 15023408.
      View in: PubMed
    62. Wilcox HM, Berg LJ. Itk phosphorylation sites are required for functional activity in primary T cells. J Biol Chem. 2003 Sep 26; 278(39):37112-21. PMID: 12842872.
      View in: PubMed
    63. Lucas JA, Miller AT, Atherly LO, Berg LJ. The role of Tec family kinases in T cell development and function. Immunol Rev. 2003 Feb; 191:119-38. PMID: 12614356.
      View in: PubMed
    64. Vergara-Silva A, Schaefer KL, Berg LJ. Compartmentalized Eph receptor and ephrin expression in the thymus. Mech Dev. 2002 Dec; 119 Suppl 1:S225-9. PMID: 14516690.
      View in: PubMed
    65. Vergara-Silva A, Schaefer KL, Berg LJ. Compartmentalized Eph receptor and ephrin expression in the thymus. Gene Expr Patterns. 2002 Dec; 2(3-4):261-5. PMID: 12617812.
      View in: PubMed
    66. Miller AT, Berg LJ. Defective Fas ligand expression and activation-induced cell death in the absence of IL-2-inducible T cell kinase. J Immunol. 2002 Mar 01; 168(5):2163-72. PMID: 11859102.
      View in: PubMed
    67. Soldevila G, Castellanos C, Malissen M, Berg LJ. Analysis of the individual role of the TCRzeta chain in transgenic mice after conditional activation with chemical inducers of dimerization. Cell Immunol. 2001 Dec 15; 214(2):123-38. PMID: 12088411.
      View in: PubMed
    68. Berg LJ, Kang J. Molecular determinants of TCR expression and selection. Curr Opin Immunol. 2001 Apr; 13(2):232-41. PMID: 11228418.
      View in: PubMed
    69. Gozalo-Sanmillan S, McNally JM, Lin MY, Chambers CA, Berg LJ. Cutting edge: two distinct mechanisms lead to impaired T cell homeostasis in Janus kinase 3- and CTLA-4-deficient mice. J Immunol. 2001 Jan 15; 166(2):727-30. PMID: 11145642.
      View in: PubMed
    70. Yang WC, Ching KA, Tsoukas CD, Berg LJ. Tec kinase signaling in T cells is regulated by phosphatidylinositol 3-kinase and the Tec pleckstrin homology domain. J Immunol. 2001 Jan 01; 166(1):387-95. PMID: 11123316.
      View in: PubMed
    71. Baird AM, Lucas JA, Berg LJ. A profound deficiency in thymic progenitor cells in mice lacking Jak3. J Immunol. 2000 Oct 01; 165(7):3680-8. PMID: 11034372.
      View in: PubMed
    72. Berg L, R?nnelid J, Klareskog L, Bucht A. Down-regulation of the T cell receptor CD3 zeta chain in rheumatoid arthritis (RA) and its influence on T cell responsiveness. Clin Exp Immunol. 2000 Apr; 120(1):174-82. PMID: 10759780.
      View in: PubMed
    73. Bunnell SC, Diehn M, Yaffe MB, Findell PR, Cantley LC, Berg LJ. Biochemical interactions integrating Itk with the T cell receptor-initiated signaling cascade. J Biol Chem. 2000 Jan 21; 275(3):2219-30. PMID: 10636929.
      View in: PubMed
    74. Thomis DC, Aramburu J, Berg LJ. The Jak family tyrosine kinase Jak3 is required for IL-2 synthesis by naive/resting CD4+ T cells. J Immunol. 1999 Nov 15; 163(10):5411-7. PMID: 10553066.
      View in: PubMed
    75. Grossman WJ, Verbsky JW, Yang L, Berg LJ, Fields LE, Chaplin DD, Ratner L. Dysregulated myelopoiesis in mice lacking Jak3. Blood. 1999 Aug 01; 94(3):932-9. PMID: 10419884.
      View in: PubMed
    76. Fernandes DM, Baird AM, Berg LJ, Rock KL. A monoclonal antibody reactive with a 40-kDa molecule on fetal thymocytes and tumor cells blocks proliferation and stimulates aggregation and apoptosis. J Immunol. 1999 Aug 01; 163(3):1306-14. PMID: 10415028.
      View in: PubMed
    77. Baird AM, Gerstein RM, Berg LJ. The role of cytokine receptor signaling in lymphocyte development. Curr Opin Immunol. 1999 Apr; 11(2):157-66. PMID: 10322150.
      View in: PubMed
    78. Yelon D, Schaefer KL, Berg LJ. Alterations in CD4-binding regions of the MHC class II molecule I-Ek do not impede CD4+ T cell development. J Immunol. 1999 Feb 01; 162(3):1348-58. PMID: 9973389.
      View in: PubMed
    79. Durum SK, Cand?ias S, Nakajima H, Leonard WJ, Baird AM, Berg LJ, Muegge K. Interleukin 7 receptor control of T cell receptor gamma gene rearrangement: role of receptor-associated chains and locus accessibility. J Exp Med. 1998 Dec 21; 188(12):2233-41. PMID: 9858510.
      View in: PubMed
    80. Baird AM, Thomis DC, Berg LJ. T cell development and activation in Jak3-deficient mice. J Leukoc Biol. 1998 Jun; 63(6):669-77. PMID: 9620658.
      View in: PubMed
    81. Liu KQ, Bunnell SC, Gurniak CB, Berg LJ. T cell receptor-initiated calcium release is uncoupled from capacitative calcium entry in Itk-deficient T cells. J Exp Med. 1998 May 18; 187(10):1721-7. PMID: 9584150.
      View in: PubMed
    82. Bunnell SC, Berg LJ. The signal transduction of motion and antigen recognition: factors affecting T cell function and differentiation. Genet Eng (N Y). 1998; 20:63-110. PMID: 9666556.
      View in: PubMed
    83. Thomis DC, Lee W, Berg LJ. T cells from Jak3-deficient mice have intact TCR signaling, but increased apoptosis. J Immunol. 1997 Nov 15; 159(10):4708-19. PMID: 9366394.
      View in: PubMed
    84. Heyeck SD, Wilcox HM, Bunnell SC, Berg LJ. Lck phosphorylates the activation loop tyrosine of the Itk kinase domain and activates Itk kinase activity. J Biol Chem. 1997 Oct 03; 272(40):25401-8. PMID: 9312162.
      View in: PubMed
    85. Thomis DC, Berg LJ. The role of Jak3 in lymphoid development, activation, and signaling. Curr Opin Immunol. 1997 Aug; 9(4):541-7. PMID: 9287175.
      View in: PubMed
    86. Yelon D, Berg LJ. Structurally similar TCRs differ in their efficiency of positive selection. J Immunol. 1997 Jun 01; 158(11):5219-28. PMID: 9164939.
      View in: PubMed
    87. Thomis DC, Berg LJ. Peripheral expression of Jak3 is required to maintain T lymphocyte function. J Exp Med. 1997 Jan 20; 185(2):197-206. PMID: 9016869.
      View in: PubMed
    88. Andreotti AH, Bunnell SC, Feng S, Berg LJ, Schreiber SL. Regulatory intramolecular association in a tyrosine kinase of the Tec family. Nature. 1997 Jan 02; 385(6611):93-7. PMID: 8985255.
      View in: PubMed
    89. Gurniak CB, Thomis DC, Berg LJ. Genomic structure and promoter region of the murine Janus-family tyrosine kinase, Jak3. DNA Cell Biol. 1997 Jan; 16(1):85-94. PMID: 9022047.
      View in: PubMed
    90. Bunnell SC, Henry PA, Kolluri R, Kirchhausen T, Rickles RJ, Berg LJ. Identification of Itk/Tsk Src homology 3 domain ligands. J Biol Chem. 1996 Oct 11; 271(41):25646-56. PMID: 8810341.
      View in: PubMed
    91. Kammer W, Lischke A, Moriggl R, Groner B, Ziemiecki A, Gurniak CB, Berg LJ, Friedrich K. Homodimerization of interleukin-4 receptor alpha chain can induce intracellular signaling. J Biol Chem. 1996 Sep 27; 271(39):23634-7. PMID: 8798580.
      View in: PubMed
    92. Fayolle C, Abdel-Motal UM, Berg L, Deriaud E, Jondal M, Leclerc C. Induction of cytotoxic T-cell response by optimal-length peptides does not require CD4+ T-cell help. Immunology. 1996 Sep; 89(1):41-5. PMID: 8911138.
      View in: PubMed
    93. Gurniak CB, Berg LJ. A new member of the Eph family of receptors that lacks protein tyrosine kinase activity. Oncogene. 1996 Aug 15; 13(4):777-86. PMID: 8761299.
      View in: PubMed
    94. Lyons DS, Lieberman SA, Hampl J, Boniface JJ, Chien Y, Berg LJ, Davis MM. A TCR binds to antagonist ligands with lower affinities and faster dissociation rates than to agonists. Immunity. 1996 Jul; 5(1):53-61. PMID: 8758894.
      View in: PubMed
    95. Yelon D, Spain LM, Lim K, Berg LJ. Alterations in CD4 dependence accompany T cell development and differentiation. Int Immunol. 1996 Jul; 8(7):1077-90. PMID: 8757953.
      View in: PubMed
    96. Gurniak CB, Berg LJ. Murine JAK3 is preferentially expressed in hematopoietic tissues and lymphocyte precursor cells. Blood. 1996 Apr 15; 87(8):3151-60. PMID: 8605329.
      View in: PubMed
    97. Thomis DC, Gurniak CB, Tivol E, Sharpe AH, Berg LJ. Defects in B lymphocyte maturation and T lymphocyte activation in mice lacking Jak3. Science. 1995 Nov 03; 270(5237):794-7. PMID: 7481767.
      View in: PubMed
    98. Liao JC, Berg LJ, Jay DG. Chromophore-assisted laser inactivation of subunits of the T-cell receptor in living cells is spatially restricted. Photochem Photobiol. 1995 Nov; 62(5):923-9. PMID: 8570733.
      View in: PubMed
    99. Raab M, Cai YC, Bunnell SC, Heyeck SD, Berg LJ, Rudd CE. p56Lck and p59Fyn regulate CD28 binding to phosphatidylinositol 3-kinase, growth factor receptor-bound protein GRB-2, and T cell-specific protein-tyrosine kinase ITK: implications for T-cell costimulation. Proc Natl Acad Sci U S A. 1995 Sep 12; 92(19):8891-5. PMID: 7568038.
      View in: PubMed
    100. Lieberman SA, Spain LM, Wang L, Berg LJ. Enhanced T cell maturation and altered lineage commitment in T cell receptor/CD4-transgenic mice. Cell Immunol. 1995 Apr 15; 162(1):56-67. PMID: 7704911.
      View in: PubMed
    101. Wessel GM, Clark F, Berg L. A diversity of enzymes involved in the regulation of reversible tyrosine phosphorylation in sea urchin eggs and embryos. Comp Biochem Physiol B Biochem Mol Biol. 1995 Mar; 110(3):493-502. PMID: 7584825.
      View in: PubMed
    102. Spain LM, Yelon D, Berg LJ. Do the CD4 and CD8 lineages represent parallel pathways? Semin Immunol. 1994 Aug; 6(4):213-20. PMID: 8000030.
      View in: PubMed
    103. Spain LM, Jorgensen JL, Davis MM, Berg LJ. A peptide antigen antagonist prevents the differentiation of T cell receptor transgenic thymocytes. J Immunol. 1994 Feb 15; 152(4):1709-17. PMID: 8120380.
      View in: PubMed
    104. Sakaguchi S, Ermak TH, Toda M, Berg LJ, Ho W, Fazekas de St Groth B, Peterson PA, Sakaguchi N, Davis MM. Induction of autoimmune disease in mice by germline alteration of the T cell receptor gene expression. J Immunol. 1994 Feb 01; 152(3):1471-84. PMID: 7905503.
      View in: PubMed
    105. Spain LM, Berg LJ. Quantitative analysis of the efficiency of clonal deletion in the thymus. Dev Immunol. 1994; 4(1):43-53. PMID: 7620325.
      View in: PubMed
    106. Heyeck SD, Berg LJ. Developmental regulation of a murine T-cell-specific tyrosine kinase gene, Tsk. Proc Natl Acad Sci U S A. 1993 Jan 15; 90(2):669-73. PMID: 8421704.
      View in: PubMed
    107. Zhou X, Abdel Motal UM, Berg L, Jondal M. In vivo priming of cytotoxic T lymphocyte responses in relation to in vitro up-regulation of major histocompatibility complex class I molecules by short synthetic peptides. Eur J Immunol. 1992 Dec; 22(12):3085-90. PMID: 1446701.
      View in: PubMed
    108. Zhou X, Berg L, Motal UM, Jondal M. In vivo primary induction of virus-specific CTL by immunization with 9-mer synthetic peptides. J Immunol Methods. 1992 Aug 30; 153(1-2):193-200. PMID: 1517589.
      View in: PubMed
    109. Spain LM, Berg LJ. Developmental regulation of thymocyte susceptibility to deletion by "self"-peptide. J Exp Med. 1992 Jul 01; 176(1):213-23. PMID: 1319457.
      View in: PubMed
    110. Berg LJ, Frank GD, Davis MM. The effects of MHC gene dosage and allelic variation on T cell receptor selection. Cell. 1990 Mar 23; 60(6):1043-53. PMID: 2317862.
      View in: PubMed
    111. Berg LJ, Davis MM. T-cell development in T cell receptor alphabeta transgenic mice. Semin Immunol. 1989 Nov; 1(2):105-16. PMID: 15630812.
      View in: PubMed
    112. Berg LJ. Generation of the T cell repertoire. Curr Opin Immunol. 1989 Oct; 2(1):87-92. PMID: 2692626.
      View in: PubMed
    113. Berg LJ, Pullen AM, Fazekas de St Groth B, Mathis D, Benoist C, Davis MM. Antigen/MHC-specific T cells are preferentially exported from the thymus in the presence of their MHC ligand. Cell. 1989 Sep 22; 58(6):1035-46. PMID: 2476238.
      View in: PubMed
    114. Berg LJ, Fazekas de St Groth B, Pullen AM, Davis MM. Phenotypic differences between alpha beta versus beta T-cell receptor transgenic mice undergoing negative selection. Nature. 1989 Aug 17; 340(6234):559-62. PMID: 2528070.
      View in: PubMed
    115. Davis MM, Berg LJ, Lin AY, Fazekas de St Groth B, Devaux B, Sagerstrom CG, Bjorkman PJ, Elliott JF. TCR recognition and selection in vivo. Cold Spring Harb Symp Quant Biol. 1989; 54 Pt 1:119-28. PMID: 2700932.
      View in: PubMed
    116. Berg LJ, Fazekas de St Groth B, Ivars F, Goodnow CC, Gilfillan S, Garchon HJ, Davis MM. Expression of T-cell receptor alpha-chain genes in transgenic mice. Mol Cell Biol. 1988 Dec; 8(12):5459-69. PMID: 3266655.
      View in: PubMed
    Berg's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    See all (458) concept(s)
    _
    Co-Authors Expand Description
    See all (2) people
    _
    Similar People Expand Description
    See all (60) people
    _
    Same Department Expand Description
    Search Department

    Copyright © 2024 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)